00947nas a2200217 4500000000100000008004100001260001700042653001100059653002300070653001800093653001300111653001200124100002200136700001400158245004600172300001000218490000700228050003200235520044800267022001400715 1986 d c1986 Apr-Jun10aHumans10aImmunity, Cellular10aImmunotherapy10aLepromin10aleprosy1 aChattopadhyay S P1 aGupta C M00aImmunotherapy in leprosy: a new approach. a233-90 v58 aInfolep Library - available3 a
An immunotherapeutic agent prepared from patient's own affected skin was tried in 30 leprosy cases. 53.6% cases of lepromatous and borderline lepromatous group showed lepromin conversion from lepromin negativity to positivity after 12 weeks of immunotherapy. The clinical and bacteriological improvement was also good. 88.1% cases of borderline tuberculoid also showed fair to good clinical recovery following 12 weeks of immunotherapy.
a0254-9395